Global Prophylactic HIV Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prophylactic HIV Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Prophylactic HIV Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Prophylactic HIV Drug by Country/Region, 2017, 2022 & 2028

2.2 Prophylactic HIV Drug Segment by Type

2.2.1 Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)

2.2.2 Integrase Inhibitor

2.3 Prophylactic HIV Drug Sales by Type

2.3.1 Global Prophylactic HIV Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Prophylactic HIV Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Prophylactic HIV Drug Sale Price by Type (2017-2022)

2.4 Prophylactic HIV Drug Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacy

2.4.3 Online Pharmacy

2.5 Prophylactic HIV Drug Sales by Application

2.5.1 Global Prophylactic HIV Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Prophylactic HIV Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Prophylactic HIV Drug Sale Price by Application (2017-2022)

3 Global Prophylactic HIV Drug by Company

3.1 Global Prophylactic HIV Drug Breakdown Data by Company

3.1.1 Global Prophylactic HIV Drug Annual Sales by Company (2020-2022)

3.1.2 Global Prophylactic HIV Drug Sales Market Share by Company (2020-2022)

3.2 Global Prophylactic HIV Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Prophylactic HIV Drug Revenue by Company (2020-2022)

3.2.2 Global Prophylactic HIV Drug Revenue Market Share by Company (2020-2022)

3.3 Global Prophylactic HIV Drug Sale Price by Company

3.4 Key Manufacturers Prophylactic HIV Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prophylactic HIV Drug Product Location Distribution

3.4.2 Players Prophylactic HIV Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prophylactic HIV Drug by Geographic Region

4.1 World Historic Prophylactic HIV Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Prophylactic HIV Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Prophylactic HIV Drug Annual Revenue by Geographic Region

4.2 World Historic Prophylactic HIV Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Prophylactic HIV Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Prophylactic HIV Drug Annual Revenue by Country/Region

4.3 Americas Prophylactic HIV Drug Sales Growth

4.4 APAC Prophylactic HIV Drug Sales Growth

4.5 Europe Prophylactic HIV Drug Sales Growth

4.6 Middle East & Africa Prophylactic HIV Drug Sales Growth

5 Americas

5.1 Americas Prophylactic HIV Drug Sales by Country

5.1.1 Americas Prophylactic HIV Drug Sales by Country (2017-2022)

5.1.2 Americas Prophylactic HIV Drug Revenue by Country (2017-2022)

5.2 Americas Prophylactic HIV Drug Sales by Type

5.3 Americas Prophylactic HIV Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prophylactic HIV Drug Sales by Region

6.1.1 APAC Prophylactic HIV Drug Sales by Region (2017-2022)

6.1.2 APAC Prophylactic HIV Drug Revenue by Region (2017-2022)

6.2 APAC Prophylactic HIV Drug Sales by Type

6.3 APAC Prophylactic HIV Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Prophylactic HIV Drug by Country

7.1.1 Europe Prophylactic HIV Drug Sales by Country (2017-2022)

7.1.2 Europe Prophylactic HIV Drug Revenue by Country (2017-2022)

7.2 Europe Prophylactic HIV Drug Sales by Type

7.3 Europe Prophylactic HIV Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prophylactic HIV Drug by Country

8.1.1 Middle East & Africa Prophylactic HIV Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Prophylactic HIV Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Prophylactic HIV Drug Sales by Type

8.3 Middle East & Africa Prophylactic HIV Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Prophylactic HIV Drug

10.3 Manufacturing Process Analysis of Prophylactic HIV Drug

10.4 Industry Chain Structure of Prophylactic HIV Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Prophylactic HIV Drug Distributors

11.3 Prophylactic HIV Drug Customer

12 World Forecast Review for Prophylactic HIV Drug by Geographic Region

12.1 Global Prophylactic HIV Drug Market Size Forecast by Region

12.1.1 Global Prophylactic HIV Drug Forecast by Region (2023-2028)

12.1.2 Global Prophylactic HIV Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Prophylactic HIV Drug Forecast by Type

12.7 Global Prophylactic HIV Drug Forecast by Application

13 Key Players Analysis

13.1 Gilead Sciences

13.1.1 Gilead Sciences Company Information

13.1.2 Gilead Sciences Prophylactic HIV Drug Product Offered

13.1.3 Gilead Sciences Prophylactic HIV Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Gilead Sciences Main Business Overview

13.1.5 Gilead Sciences Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Prophylactic HIV Drug Product Offered

13.2.3 Merck Prophylactic HIV Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Mylan

13.3.1 Mylan Company Information

13.3.2 Mylan Prophylactic HIV Drug Product Offered

13.3.3 Mylan Prophylactic HIV Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mylan Main Business Overview

13.3.5 Mylan Latest Developments

13.4 Cipla

13.4.1 Cipla Company Information

13.4.2 Cipla Prophylactic HIV Drug Product Offered

13.4.3 Cipla Prophylactic HIV Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Cipla Main Business Overview

13.4.5 Cipla Latest Developments

13.5 Bristol-Myers Squibb

13.5.1 Bristol-Myers Squibb Company Information

13.5.2 Bristol-Myers Squibb Prophylactic HIV Drug Product Offered

13.5.3 Bristol-Myers Squibb Prophylactic HIV Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bristol-Myers Squibb Main Business Overview

13.5.5 Bristol-Myers Squibb Latest Developments

13.6 Roche

13.6.1 Roche Company Information

13.6.2 Roche Prophylactic HIV Drug Product Offered

13.6.3 Roche Prophylactic HIV Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Roche Main Business Overview

13.6.5 Roche Latest Developments

14 Research Findings and Conclusion

Table 1. Prophylactic HIV Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Prophylactic HIV Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)

Table 4. Major Players of Integrase Inhibitor

Table 5. Global Prophylactic HIV Drug Sales by Type (2017-2022) & (K Units)

Table 6. Global Prophylactic HIV Drug Sales Market Share by Type (2017-2022)

Table 7. Global Prophylactic HIV Drug Revenue by Type (2017-2022) & ($ million)

Table 8. Global Prophylactic HIV Drug Revenue Market Share by Type (2017-2022)

Table 9. Global Prophylactic HIV Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Prophylactic HIV Drug Sales by Application (2017-2022) & (K Units)

Table 11. Global Prophylactic HIV Drug Sales Market Share by Application (2017-2022)

Table 12. Global Prophylactic HIV Drug Revenue by Application (2017-2022)

Table 13. Global Prophylactic HIV Drug Revenue Market Share by Application (2017-2022)

Table 14. Global Prophylactic HIV Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Prophylactic HIV Drug Sales by Company (2020-2022) & (K Units)

Table 16. Global Prophylactic HIV Drug Sales Market Share by Company (2020-2022)

Table 17. Global Prophylactic HIV Drug Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Prophylactic HIV Drug Revenue Market Share by Company (2020-2022)

Table 19. Global Prophylactic HIV Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Prophylactic HIV Drug Producing Area Distribution and Sales Area

Table 21. Players Prophylactic HIV Drug Products Offered

Table 22. Prophylactic HIV Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Prophylactic HIV Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Prophylactic HIV Drug Sales Market Share Geographic Region (2017-2022)

Table 27. Global Prophylactic HIV Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Prophylactic HIV Drug Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Prophylactic HIV Drug Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Prophylactic HIV Drug Sales Market Share by Country/Region (2017-2022)

Table 31. Global Prophylactic HIV Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Prophylactic HIV Drug Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Prophylactic HIV Drug Sales by Country (2017-2022) & (K Units)

Table 34. Americas Prophylactic HIV Drug Sales Market Share by Country (2017-2022)

Table 35. Americas Prophylactic HIV Drug Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Prophylactic HIV Drug Revenue Market Share by Country (2017-2022)

Table 37. Americas Prophylactic HIV Drug Sales by Type (2017-2022) & (K Units)

Table 38. Americas Prophylactic HIV Drug Sales Market Share by Type (2017-2022)

Table 39. Americas Prophylactic HIV Drug Sales by Application (2017-2022) & (K Units)

Table 40. Americas Prophylactic HIV Drug Sales Market Share by Application (2017-2022)

Table 41. APAC Prophylactic HIV Drug Sales by Region (2017-2022) & (K Units)

Table 42. APAC Prophylactic HIV Drug Sales Market Share by Region (2017-2022)

Table 43. APAC Prophylactic HIV Drug Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Prophylactic HIV Drug Revenue Market Share by Region (2017-2022)

Table 45. APAC Prophylactic HIV Drug Sales by Type (2017-2022) & (K Units)

Table 46. APAC Prophylactic HIV Drug Sales Market Share by Type (2017-2022)

Table 47. APAC Prophylactic HIV Drug Sales by Application (2017-2022) & (K Units)

Table 48. APAC Prophylactic HIV Drug Sales Market Share by Application (2017-2022)

Table 49. Europe Prophylactic HIV Drug Sales by Country (2017-2022) & (K Units)

Table 50. Europe Prophylactic HIV Drug Sales Market Share by Country (2017-2022)

Table 51. Europe Prophylactic HIV Drug Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Prophylactic HIV Drug Revenue Market Share by Country (2017-2022)

Table 53. Europe Prophylactic HIV Drug Sales by Type (2017-2022) & (K Units)

Table 54. Europe Prophylactic HIV Drug Sales Market Share by Type (2017-2022)

Table 55. Europe Prophylactic HIV Drug Sales by Application (2017-2022) & (K Units)

Table 56. Europe Prophylactic HIV Drug Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Prophylactic HIV Drug Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Prophylactic HIV Drug Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Prophylactic HIV Drug Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Prophylactic HIV Drug Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Prophylactic HIV Drug Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Prophylactic HIV Drug Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Prophylactic HIV Drug Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Prophylactic HIV Drug Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Prophylactic HIV Drug

Table 66. Key Market Challenges & Risks of Prophylactic HIV Drug

Table 67. Key Industry Trends of Prophylactic HIV Drug

Table 68. Prophylactic HIV Drug Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Prophylactic HIV Drug Distributors List

Table 71. Prophylactic HIV Drug Customer List

Table 72. Global Prophylactic HIV Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Prophylactic HIV Drug Sales Market Forecast by Region

Table 74. Global Prophylactic HIV Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Prophylactic HIV Drug Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Prophylactic HIV Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Prophylactic HIV Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Prophylactic HIV Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Prophylactic HIV Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Prophylactic HIV Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Prophylactic HIV Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Prophylactic HIV Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Prophylactic HIV Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Prophylactic HIV Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Prophylactic HIV Drug Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Prophylactic HIV Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Prophylactic HIV Drug Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Prophylactic HIV Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Prophylactic HIV Drug Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Prophylactic HIV Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Prophylactic HIV Drug Revenue Market Share Forecast by Application (2023-2028)

Table 92. Gilead Sciences Basic Information, Prophylactic HIV Drug Manufacturing Base, Sales Area and Its Competitors

Table 93. Gilead Sciences Prophylactic HIV Drug Product Offered

Table 94. Gilead Sciences Prophylactic HIV Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Gilead Sciences Main Business

Table 96. Gilead Sciences Latest Developments

Table 97. Merck Basic Information, Prophylactic HIV Drug Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Prophylactic HIV Drug Product Offered

Table 99. Merck Prophylactic HIV Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Merck Main Business

Table 101. Merck Latest Developments

Table 102. Mylan Basic Information, Prophylactic HIV Drug Manufacturing Base, Sales Area and Its Competitors

Table 103. Mylan Prophylactic HIV Drug Product Offered

Table 104. Mylan Prophylactic HIV Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Mylan Main Business

Table 106. Mylan Latest Developments

Table 107. Cipla Basic Information, Prophylactic HIV Drug Manufacturing Base, Sales Area and Its Competitors

Table 108. Cipla Prophylactic HIV Drug Product Offered

Table 109. Cipla Prophylactic HIV Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Cipla Main Business

Table 111. Cipla Latest Developments

Table 112. Bristol-Myers Squibb Basic Information, Prophylactic HIV Drug Manufacturing Base, Sales Area and Its Competitors

Table 113. Bristol-Myers Squibb Prophylactic HIV Drug Product Offered

Table 114. Bristol-Myers Squibb Prophylactic HIV Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Bristol-Myers Squibb Main Business

Table 116. Bristol-Myers Squibb Latest Developments

Table 117. Roche Basic Information, Prophylactic HIV Drug Manufacturing Base, Sales Area and Its Competitors

Table 118. Roche Prophylactic HIV Drug Product Offered

Table 119. Roche Prophylactic HIV Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Roche Main Business

Table 121. Roche Latest Developments

List of Figures

Figure 1. Picture of Prophylactic HIV Drug

Figure 2. Prophylactic HIV Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prophylactic HIV Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Prophylactic HIV Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Prophylactic HIV Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)

Figure 10. Product Picture of Integrase Inhibitor

Figure 11. Global Prophylactic HIV Drug Sales Market Share by Type in 2021

Figure 12. Global Prophylactic HIV Drug Revenue Market Share by Type (2017-2022)

Figure 13. Prophylactic HIV Drug Consumed in Hospital Pharmacy

Figure 14. Global Prophylactic HIV Drug Market: Hospital Pharmacy (2017-2022) & (K Units)

Figure 15. Prophylactic HIV Drug Consumed in Retail Pharmacy

Figure 16. Global Prophylactic HIV Drug Market: Retail Pharmacy (2017-2022) & (K Units)

Figure 17. Prophylactic HIV Drug Consumed in Online Pharmacy

Figure 18. Global Prophylactic HIV Drug Market: Online Pharmacy (2017-2022) & (K Units)

Figure 19. Global Prophylactic HIV Drug Sales Market Share by Application (2017-2022)

Figure 20. Global Prophylactic HIV Drug Revenue Market Share by Application in 2021

Figure 21. Prophylactic HIV Drug Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Prophylactic HIV Drug Revenue Market Share by Company in 2021

Figure 23. Global Prophylactic HIV Drug Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Prophylactic HIV Drug Revenue Market Share by Geographic Region in 2021

Figure 25. Global Prophylactic HIV Drug Sales Market Share by Region (2017-2022)

Figure 26. Global Prophylactic HIV Drug Revenue Market Share by Country/Region in 2021

Figure 27. Americas Prophylactic HIV Drug Sales 2017-2022 (K Units)

Figure 28. Americas Prophylactic HIV Drug Revenue 2017-2022 ($ Millions)

Figure 29. APAC Prophylactic HIV Drug Sales 2017-2022 (K Units)

Figure 30. APAC Prophylactic HIV Drug Revenue 2017-2022 ($ Millions)

Figure 31. Europe Prophylactic HIV Drug Sales 2017-2022 (K Units)

Figure 32. Europe Prophylactic HIV Drug Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Prophylactic HIV Drug Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Prophylactic HIV Drug Revenue 2017-2022 ($ Millions)

Figure 35. Americas Prophylactic HIV Drug Sales Market Share by Country in 2021

Figure 36. Americas Prophylactic HIV Drug Revenue Market Share by Country in 2021

Figure 37. United States Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Prophylactic HIV Drug Sales Market Share by Region in 2021

Figure 42. APAC Prophylactic HIV Drug Revenue Market Share by Regions in 2021

Figure 43. China Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Prophylactic HIV Drug Sales Market Share by Country in 2021

Figure 50. Europe Prophylactic HIV Drug Revenue Market Share by Country in 2021

Figure 51. Germany Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Prophylactic HIV Drug Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Prophylactic HIV Drug Revenue Market Share by Country in 2021

Figure 58. Egypt Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Prophylactic HIV Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Prophylactic HIV Drug in 2021

Figure 64. Manufacturing Process Analysis of Prophylactic HIV Drug

Figure 65. Industry Chain Structure of Prophylactic HIV Drug

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles